Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement In Brief

This article was originally published in The Gray Sheet

Executive Summary

CMS opens national coverage analysis on VADs, proposes regulatory reform and announces new ESRD initiative. More reimbursement news.

You may also be interested in...



Reimbursement Briefs: CMS Looks Ahead On Competitive Bidding; Comment Requests

CMS requests comments on competitive bidding program, extends deadline for information requested on two prospective models for paying specialty practitioners for services in the outpatient setting, and requests comments on quality measures for ESRD initiative. Ocular Therapeutix receives a Category III CPT code.

Reimbursement In Brief

Round two DMEPOS competitive bidding launched July 1 despite efforts by durable medical equipment makers and suppliers to delay it. OIG reports to CMS on continuous positive airway pressure supplies and therapeutic shoes. More reimbursement news.

Reimbursement In Brief

HHS Office of Inspector General says Illinois should reduce Medicaid rates for diabetes test strips, and that Medicare is paying so-called G modifier claims inappropriately in reports last week. More reimbursement news.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032725

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel